USE OF NEBIVOLOL FOR PRODUCING ANTI-ATHEROGENIC PHARMACEUTICALS AND COMBINATION PHARMACEUTICALS CONTAINING THEM

摘要

This invention relates to the use of an alpha , alpha '-iminobis(methylene)bis[2-chromanmethanol] derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and conditions of the vascular and nervous system which are associated with oxidative stress.